MicroRNA Crop Yield Optimization Using Natural Plant Biological Mechanisms

Global crop production faces compounding challenges from arable land constraints, changing climate patterns, and strict regulatory limits on synthetic chemical inputs. Syngenta has announced EXORT technology, a biological platform designed to modulate endogenous plant regulatory pathways to elevate crop productivity and harvest quality. The company plans to commercialize the first formulations derived from this platform beginning in 2027, followed by a phased market introduction across approximately 20 countries.

Biological Mechanism and MicroRNA Gene Regulation
Conventional agrochemical inputs typically rely on external synthetic chemistries or broad microbial inoculants to protect crops or supply supplemental nutrients. EXORT technology operates directly on post-transcriptional gene regulation by using natural microRNAs, which are non-coding ribonucleic acid molecules that regulate gene expression within plant physiology. These endogenous molecules direct cellular machinery to down-regulate specific messenger RNA targets, fine-tuning biological pathways responsible for vegetative development, grain filling, and environmental stress adaptation.

By identifying and synthesizing specific naturally occurring microRNA sequences through genomics and bioinformatics analysis, the platform provides precise biological signaling. Delivered as a foliar spray at low application rates, the microRNA molecules enter leaf tissue to trigger the plant's native regulatory cascades. This enables crops to reallocate metabolic resources toward reproductive growth, resulting in larger grain sizes and improved fruit and vegetable quality without requiring genetic modifications to the crop genome.

Agronomic Integration and Multi-Crop Field Validation
The biological formulation is designed for direct compatibility with standard agronomic workflows, requiring no specialized application machinery or changes to standard field management practices. The platform has completed multi-year agronomic evaluation trials across diverse geographic zones and soil profiles. Field testing validated consistent yield increases across multiple broadacre and specialty crop sectors, including rice, soybean, corn, cotton, fruits, and vegetables.

Discussing the platform architecture, Camilla Corsi, Head of Crop Protection Research and Development at Syngenta, stated that the system translates fundamental microRNA signaling mechanisms into an applied agricultural input. Corsi explained that developments across genomic sequencing and plant bioinformatics have made it possible to target and deliver specific regulatory RNA molecules with high precision, optimizing internal metabolic efficiency while adhering to sustainable farming targets.

Additional Context:
This section details technical specifications and competitive benchmarking not included in the original product announcement.

Exogenous application of ribonucleic acids represents an emerging class of biological inputs governed by spray-induced gene silencing (SIGS) and endogenous pathway modulation. While double-stranded RNA (dsRNA) biopesticides primarily target external pest transcripts via post-transcriptional gene silencing (PTGS) under OECD regulatory frameworks for RNA-based agricultural inputs, foliar microRNA applications target endogenous plant pathways to modulate yield and abiotic stress tolerance.

Comparative performance benchmarks in broadacre biostimulants typically evaluate microRNA platforms against peptide-based signaling compounds, seaweed extracts, and humic/fulvic acid formulations. Whereas standard microbial or humic biostimulants exhibit broad, non-specific physiological responses with field variability ranging from 2% to 7% yield increases depending on microbiome compatibility, RNA-guided approaches offer sequence-specific targeted regulation. Research following the 2024 Nobel Prize recognition of microRNA mechanics indicates that delivery stability against foliar ribonucleases and cuticular penetration remain the primary engineering benchmarks for commercial field-scale RNA formulations.

Edited by Natania Lyngdoh, Induportals editor, with AI assistance.

www.syngenta.com